Use of Immunotherapy in RCC Asim Amin, M.D., PhD.

Dr. Amin on Rationale for CheckMate-214 Trial in RCCПодробнее

Dr. Amin on Next Steps With Immunotherapy in Advanced RCCПодробнее

Navigating Evolving Standards of Care in RCC: Novel Targeted and Immunotherapy OptionsПодробнее

Dr. McDermott on TKI/Immunotherapy Combinations in RCCПодробнее

Dr. Choueiri on Using Immunotherapy to Treat RCCПодробнее

Dr. Harshman on Earlier Use of Immunotherapy in RCCПодробнее

Immunotherapy for Cancer A double edged sword Asim AminПодробнее

Dr. Amin on Toxicities With Immunotherapy/TKI Combinations in RCCПодробнее

Dr. Amin on Evaluating Response to Immunotherapy in RCCПодробнее

Recent immunotherapy advances in RCCПодробнее

Dr. Sznol on Immunotherapy in Patients With RCCПодробнее

Dr. Choueiri on the Research With Immunotherapy in RCCПодробнее

Dr. McGregor on Combination Therapies With Nivolumab, Cabozantinib, and Sunitinib in RCCПодробнее

Dr. Gupta Discusses Combination Immunotherapy in RCCПодробнее

Dr. Hammers on Next Steps with Immunotherapy in RCCПодробнее

Dr. Choueiri Discusses Immunotherapy in RCCПодробнее

Clinically Meaningful Outcomes Among Expanding Treatment Options in RCCПодробнее

Immunotherapy Combination Strategies in RCCПодробнее

Dr. Hammers on Study of HyperAcute Renal Immunotherapy in RCCПодробнее